Prati
Christoph T. Berger
Christoph T. Berger
Potvrđena adresa e-pošte na usb.ch
Naslov
Citirano
Citirano
Godina
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
ME Ackerman, B Moldt, RT Wyatt, AS Dugast, E McAndrew, S Tsoukas, ...
Journal of immunological methods 366 (1-2), 8-19, 2011
4472011
Computational strategies for dissecting the high-dimensional complexity of adaptive immune repertoires
E Miho, A Yermanos, CR Weber, CT Berger, ST Reddy, V Greiff
Frontiers in Immunology 9, 224, 2018
1882018
Definition of the viral targets of protective HIV-1-specific T cell responses
B Mothe, A Llano, J Ibarrondo, M Daniels, C Miranda, J Zamarreño, ...
Journal of translational medicine 9 (1), 208, 2011
1882011
High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control
CT Berger, N Frahm, DA Price, B Mothe, M Ghebremichael, KL Hartman, ...
Journal of virology 85 (18), 9334-9345, 2011
1612011
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control
B Mothe, A Llano, J Ibarrondo, J Zamarreño, M Schiaulini, C Miranda, ...
PloS one 7 (1), e29717, 2012
1552012
Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy
P Blyszczuk, G Kania, T Dieterle, RR Marty, A Valaperti, C Berthonneche, ...
Circulation research 105 (9), 912-920, 2009
1362009
Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors
DC Kroy, D Ciuffreda, JH Cooperrider, M Tomlinson, GD Hauck, J Aneja, ...
Gastroenterology 146 (2), 550-561, 2014
1132014
Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells
YJ Yamanaka, CT Berger, M Sips, PC Cheney, G Alter, JC Love
Integrative Biology 4 (10), 1175-1184, 2012
1102012
High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition
CT Berger, M Wolbers, P Meyer, T Daikeler, C Hess
Rheumatology 48 (3), 258-261, 2009
1042009
Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals
AS Dugast, A Tonelli, CT Berger, ME Ackerman, G Sciaranghella, Q Liu, ...
Virology 415 (2), 160-167, 2011
992011
The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement.
M Aschwanden, S Imfeld, D Staub, T Baldi, UA Walker, CT Berger, C Hess, ...
Clinical and experimental rheumatology 33 (2 Suppl 89), S-113-5, 2015
972015
A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis
FD Carmona, A Vaglio, SL Mackie, J Hernández-Rodríguez, PA Monach, ...
The American Journal of Human Genetics 100 (1), 64-74, 2017
922017
A patient’s wish: anakinra in pregnancy
CT Berger, M Recher, U Steiner, TM Hauser
Annals of the rheumatic diseases 68 (11), 1794-1795, 2009
862009
Altered distribution of mucosal NK cells during HIV infection
M Sips, G Sciaranghella, T Diefenbach, AS Dugast, CT Berger, Q Liu, ...
Mucosal immunology 5 (1), 30, 2012
772012
Viral adaptation to immune selection pressure by HLA class I–restricted CTL responses targeting epitopes in HIV frameshift sequences
CT Berger, JM Carlson, CJ Brumme, KL Hartman, ZL Brumme, LM Henry, ...
Journal of Experimental Medicine 207 (1), 61-75, 2010
692010
Serum neurofilament light chain: a biomarker of neuronal injury in vasculitic neuropathy
A Bischof, T Manigold, C Barro, I Heijnen, CT Berger, T Derfuss, J Kuhle, ...
Annals of the rheumatic diseases, annrheumdis-2017-212045, 2017
642017
Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study
M Aschwanden, E Schegk, S Imfeld, D Staub, C Rottenburger, CT Berger, ...
Rheumatology, 2018
512018
The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis
CT Berger, G Sommer, M Aschwanden, D Staub, C Rottenburger, ...
Swiss medical weekly 148 (3334), 2018
492018
Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations
TM Nordmann, FD Juengling, M Recher, CT Berger, D Kalbermatten, ...
Blood 129 (7), 879-882, 2017
492017
Maternal laboratory stress influences fetal neurobehavior: cortisol does not provide all answers
NS Fink, C Urech, CT Berger, I Hoesli, W Holzgreve, J Bitzer, J Alder
The Journal of Maternal-Fetal & Neonatal Medicine 23 (6), 488-500, 2010
462010
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20